As of 2021, approval from the National Pharmaceutical Control Agency (NPRA) will be mandatory for clinical use of Cell & Gene Therapy Products (CGTP). 

• DTERM will only consider providing Contract Manufacturing Services for sponsors with Clinical Trial Exemption / Clinical Trial Import License issued by NPRA and for commercial products approved/ licensed by NPRA. 
•  
• You are advised to verify with the National Pharmaceutical Control Agency (NPRA) directly on the approval for clinical use of any cells and gene therapy products (CGTP).  
•     
• Consultation with qualified healthcare professionals is recommended before clinical use of such products. 
•  
• Administration of such products in patients should be strictly performed by a qualified healthcare personnel / team.
•  
• Any claims that cells/stem cells/exosomes produced by DTERM should be verified with us directly through email at dtermfper@ukm.edu.my or kjdterm@ukm.edu.my. 
•  
• Any use of DTERM or UKM logo in marketing materials including brochures, presentations, social media, etc. should obtain written consent from DTERM or and by extension UKM legal department. Any misrepresentation of DTERM or its members are therefore liable to legal actions.